Income Statement 3SBio Inc.

Equities

1530

KYG8875G1029

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 08:08:25 16/01/2026 GMT			5-day change	1st Jan Change
26.48 ^HKD	-1.78%		-4.27%	+9.51%

12-02	3SBio Seeks HK$3.12 Billion via Share Sale	MT
12-02	3SBio to place 105.2 million shares	RE

9446d686e8a91ddcc74a20.NZ2YppNwPa3KJFJRPhHU8eHIVB5j3pHmGqbn8764-Zk.eav86sQXcfWdbhhkUXrmhq6YBUw0mMmeQP6BlueJvu9kxdHD_F13zKZjIQ

Published financial data: 3SBIO INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.59B	6.38B	6.86B	7.82B	9.11B
Total Revenues	5.59B	6.38B	6.86B	7.82B	9.11B
Cost of Goods Sold, Total	1.06B	1.11B	1.19B	1.17B	1.28B
Gross Profit	4.52B	5.28B	5.67B	6.64B	7.83B
Selling General & Admin Expenses, Total	2.47B	2.7B	2.96B	3.49B	3.85B
R&D Expenses	590M	754M	693M	795M	1.33B
Other Operating Expenses	121M	140M	106M	442M	36.93M
Other Operating Expenses, Total	3.18B	3.59B	3.76B	4.72B	5.22B
Operating Income	1.34B	1.69B	1.91B	1.92B	2.61B
Interest Expense, Total	-81.07M	-66.52M	-101M	-212M	-191M
Interest And Investment Income	84.5M	103M	151M	153M	148M
Net Interest Expenses	3.44M	36.14M	49.6M	-59.17M	-43.06M
Income (Loss) On Equity Invest.	-30.39M	-37.1M	-33.65M	-29.8M	349M
Currency Exchange Gains (Loss)	-250M	135M	275M	-	25.28M
Other Non Operating Income (Expenses)	86.52M	75.8M	82.36M	104M	116M
EBT, Excl. Unusual Items	1.15B	1.9B	2.28B	1.93B	3.06B
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	625K	-13.52M	181M	-	-284M
Gain (Loss) On Sale Of Assets	-1.02M	-13.89M	-4.27M	-1.88M	-15.08M
Asset Writedown	-178M	-	-186M	-	-41.24M
Other Unusual Items	6.53M	-	1.28M	48.27M	-
EBT, Incl. Unusual Items	979M	1.87B	2.27B	1.98B	2.72B
Income Tax Expense	208M	241M	366M	392M	501M
Earnings From Continuing Operations	771M	1.63B	1.91B	1.59B	2.22B
Net Income to Company	771M	1.63B	1.91B	1.59B	2.22B
Minority Interest	64.68M	23.67M	6.87M	-37.05M	-127M
Net Income - (IS)	836M	1.65B	1.91B	1.55B	2.09B
Net Income to Common Incl Extra Items	836M	1.65B	1.91B	1.55B	2.09B
Net Income to Common Excl. Extra Items	836M	1.65B	1.91B	1.55B	2.09B
Per Share Items
Net EPS - Basic	0.33	0.65	0.78	0.64	0.86
Basic EPS - Continuing Operations	0.33	0.65	0.78	0.64	0.86
Basic Weighted Average Shares Outstanding	2.53B	2.54B	2.44B	2.44B	2.42B
Net EPS - Diluted	0.33	0.62	0.74	0.62	0.85
Diluted EPS - Continuing Operations	0.33	0.62	0.74	0.62	0.85
Diluted Weighted Average Shares Outstanding	2.75B	2.77B	2.65B	2.44B	2.47B
Normalized Basic EPS	0.31	0.48	0.59	0.48	0.74
Normalized Diluted EPS	0.28	0.44	0.54	0.48	0.72
Dividend Per Share	-	0.16	0.09	0.23	0.23
Payout Ratio	-	-	21.78	14.52	26.56
American Depositary Receipts Ratio (ADR)	10	10	10	10	10
Supplemental Items
EBITDA	1.68B	1.99B	2.27B	2.23B	2.98B
EBITA	1.5B	1.81B	2.09B	2.02B	2.72B
EBIT	1.34B	1.69B	1.91B	1.92B	2.61B
EBITDAR	1.69B	2B	2.27B	2.24B	2.99B
Effective Tax Rate - (Ratio)	21.25	12.91	16.1	19.82	18.42
Total Current Taxes	290M	303M	385M	392M	522M
Total Deferred Taxes	-82.27M	-61.72M	-18.53M	495K	-21.47M
Normalized Net Income	784M	1.21B	1.43B	1.17B	1.78B
Interest on Long-Term Debt	69.19M	63.26M	56.42M	27.14M	54.11M
Non-Cash Pension Expense	42K	22K	45K	176K	140K
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.02B	2.32B	2.58B	3.01B	3.35B
General and Administrative Expenses	448M	368M	380M	472M	494M
Research And Development Expense From Footnotes	590M	754M	693M	795M	1.33B
Net Rental Expense, Total	4.85M	3.2M	4.35M	8.44M	8.24M
Imputed Operating Lease Interest Expense	1.09M	615K	991K	3.06M	3M
Imputed Operating Lease Depreciation	3.77M	2.59M	3.36M	5.37M	5.24M
Stock-Based Comp., G&A Exp. (Total)	101M	31.78M	10.74M	-4.66M	29.3M
Stock-Based Comp., Other (Total)	-	-	-	-	3.16M
Total Stock-Based Compensation	101M	31.78M	10.74M	-4.66M	32.46M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3.09B	2.87B	2.15B	2.69B	2.14B
Short Term Investments	-	-	-	-	406M
Trading Asset Securities, Total	1.27B	1.9B	4.86B	3.3B	3.77B
Total Cash And Short Term Investments	4.36B	4.77B	7.01B	5.99B	6.32B
Accounts Receivable, Total	983M	1.38B	1.31B	1.1B	1.31B
Other Receivables	-16.34M	-5.38M	-23.72M	-210M	-213M
Notes Receivable	302M	206M	191M	191M	201M
Total Receivables	1.27B	1.58B	1.48B	1.08B	1.29B
Inventory	620M	691M	712M	778M	795M
Other Current Assets, Total	428M	753M	560M	1.35B	940M
Total Current Assets	6.68B	7.79B	9.76B	9.19B	9.35B
Gross Property Plant And Equipment	4.06B	5.06B	5.87B	6.68B	7.22B
Accumulated Depreciation	-1.08B	-1.24B	-1.4B	-1.62B	-1.85B
Net Property Plant And Equipment	2.98B	3.83B	4.47B	5.07B	5.37B
Long-term Investments	1.65B	1.32B	1.38B	3.13B	2.94B
Goodwill	3.92B	3.84B	4.14B	4.2B	4.25B
Other Intangibles, Total	1.9B	1.85B	1.58B	1.55B	1.68B
Accounts Receivable Long-Term	-	-	-	-	-
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	219M	280M	309M	275M	296M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	328M	299M	354M	203M	327M
Total Assets	17.68B	19.21B	21.99B	23.63B	24.21B
Liabilities
Accounts Payable, Total	203M	230M	249M	212M	180M
Accrued Expenses, Total	496M	643M	743M	994M	1.17B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	360M	150M	363M	2.11B	3.47B
Current Portion of Leases	7.01M	10.56M	12.23M	9.74M	15.27M
Current Income Taxes Payable	57.62M	73.71M	112M	32.66M	49.82M
Unearned Revenue Current, Total	69.85M	54.44M	79.24M	52.39M	50.67M
Other Current Liabilities	257M	257M	235M	315M	525M
Total Current Liabilities	1.45B	1.42B	1.79B	3.73B	5.46B
Long-Term Debt	2.51B	2.44B	4.07B	2.69B	37.63M
Long-Term Leases	32.22M	32.38M	27.59M	27.81M	31.66M
Unearned Revenue Non Current	308M	397M	417M	412M	390M
Pension & Other Post Retirement Benefits	6.28M	5.57M	4.47M	-	-
Deferred Tax Liability Non Current	272M	264M	280M	251M	249M
Other Non Current Liabilities	-	-	-	4.6M	4.47M
Total Liabilities	4.58B	4.55B	6.59B	7.11B	6.18B
Common Stock, Total	155K	155K	149K	149K	146K
Additional Paid In Capital	4.65B	4.49B	4.03B	3.81B	3.05B
Retained Earnings	5.7B	7.53B	9.03B	10.53B	12.64B
Treasury Stock	-	-	-236M	-236M	-236M
Comprehensive Income and Other	339M	202M	140M	-72.11M	-17.16M
Total Common Equity	10.69B	12.23B	12.96B	14.03B	15.44B
Minority Interest	2.4B	2.43B	2.44B	2.48B	2.6B
Total Equity	13.09B	14.66B	15.4B	16.51B	18.04B
Total Liabilities And Equity	17.68B	19.21B	21.99B	23.63B	24.21B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.54B	2.52B	2.4B	2.4B	2.36B
ECS Total Common Shares Outstanding	2.54B	2.52B	2.4B	2.4B	2.36B
Book Value / Share	4.2	4.85	5.4	5.85	6.55
Tangible Book Value	4.87B	6.53B	7.24B	8.28B	9.5B
Tangible Book Value Per Share	1.92	2.59	3.02	3.45	4.03
Total Debt	2.91B	2.63B	4.47B	4.84B	3.55B
Net Debt	-1.45B	-2.14B	-2.54B	-1.15B	-2.76B
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.28M	5.57M	4.47M	4.35M	4.47M
Debt Equivalent Oper. Leases	38.81M	25.62M	34.81M	67.5M	65.94M
Minority Interest, Total (Incl. Fin. Div)	2.4B	2.43B	2.44B	2.48B	2.6B
Equity Method Investments, Total	757M	701M	624M	596M	499M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	237M	285M	323M	325M	341M
Inventories - Work In Process, Total	263M	301M	325M	306M	302M
Inventories - Finished Goods, Total	126M	106M	94.83M	150M	155M
Land - (BS)	953M	990M	1.02B	1.42B	1.85B
Machinery, Total	1.56B	1.69B	1.99B	2.35B	2.52B
Full Time Employees	5.52K	5.29K	5.21K	5.41K	5.58K
Part Time Employees	6	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	52.43M	57.8M	65.42M	50.75M	53.38M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	836M	1.65B	1.91B	1.55B	2.09B
Depreciation & Amortization - CF	204M	206M	204M	231M	285M
Amortization of Goodwill and Intangible Assets - (CF)	157M	123M	178M	104M	110M
Depreciation & Amortization, Total	361M	329M	382M	335M	395M
Amortization of Deferred Charges, Total - (CF)	32.74M	114M	74.86M	6.11M	20.51M
(Gain) Loss From Sale Of Asset	1.02M	13.89M	4.27M	1.88M	15.08M
(Gain) Loss on Sale of Investments - (CF)	-625K	13.52M	-181M	359M	284M
Asset Writedown & Restructuring Costs	178M	-	186M	-	41.24M
(Income) Loss On Equity Investments - (CF)	30.39M	37.1M	33.65M	29.8M	-349M
Stock-Based Compensation (CF)	101M	30.27M	10.74M	-4.66M	32.46M
Provision and Write-off of Bad Debts	-18.85M	2.57M	7.63M	-14.67M	2.63M
Other Operating Activities, Total	126M	-281M	-322M	-16.2M	103M
Change In Accounts Receivable	34.88M	-401M	61.07M	231M	-213M
Change In Inventories	-93.11M	-67.15M	-50.33M	-37.26M	-18.03M
Change In Accounts Payable	53.23M	27.12M	19.09M	-37.46M	-32.5M
Change in Other Net Operating Assets	-297M	109M	40.22M	-319M	829M
Cash from Operations	1.34B	1.58B	2.18B	2.08B	3.2B
Capital Expenditure	-893M	-1.03B	-910M	-625M	-682M
Sale of Property, Plant, and Equipment	2.63M	1.58M	384K	15.38M	8.58M
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-88.49M	-79.86M	-64.17M	-79.62M	-282M
Investment in Marketable and Equity Securities, Total	-1.04B	-295M	-2.96B	-795M	-421M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-48.6M	-	-	-77.06M
Other Investing Activities, Total	146M	164M	216M	138M	95.47M
Cash from Investing	-1.87B	-1.29B	-3.72B	-1.35B	-1.36B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	3.02B	270M	2.08B	3.19B	1.53B
Total Debt Issued	3.02B	270M	2.08B	3.19B	1.53B
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-3B	-379M	-448M	-3.19B	-2.82B
Total Debt Repaid	-3B	-379M	-448M	-3.19B	-2.82B
Issuance of Common Stock	1.1M	4.13M	169K	337K	-
Repurchase of Common Stock	-11.22M	-413M	-476M	-	-242M
Common Dividends Paid	-	-	-417M	-225M	-555M
Common & Preferred Stock Dividends Paid	-	-	-417M	-225M	-555M
Other Financing Activities, Total	1.53B	36.41M	-25.89M	-126M	-174M
Cash from Financing	1.55B	-481M	715M	-353M	-2.25B
Foreign Exchange Rate Adjustments	-17.78M	-33.47M	109M	74.89M	-58.69M
Net Change in Cash	1.01B	-223M	-718M	459M	-469M
Supplemental Items
Cash Interest Paid	196M	6.26M	45.56M	122M	175M
Cash Income Tax Paid (Refund)	254M	287M	346M	471M	506M
Levered Free Cash Flow	59.4M	-152M	1.06B	423M	1.54B
Unlevered Free Cash Flow	110M	-111M	1.12B	555M	1.66B
Change In Net Working Capital	242M	531M	-432M	275M	-544M
Net Debt Issued / Repaid	27.33M	-109M	1.63B	-2.51M	-1.28B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.16	5.71	5.79	5.25	6.82
Return on Total Capital	5.73	6.33	6.42	5.81	7.6
Return On Equity %	6.58	11.73	12.7	9.95	12.84
Return on Common Equity	8.23	14.41	15.2	11.49	14.19
Margin Analysis
Gross Profit Margin %	80.98	82.67	82.69	84.98	85.95
SG&A Margin	44.25	42.24	43.22	44.61	42.31
EBITDA Margin %	30.13	31.22	33.1	28.56	32.73
EBITA Margin %	26.81	28.36	30.42	25.86	29.88
EBIT Margin %	24	26.42	27.83	24.53	28.67
Income From Continuing Operations Margin %	13.8	25.5	27.82	20.3	24.35
Net Income Margin %	14.96	25.87	27.92	19.82	22.95
Net Avail. For Common Margin %	14.96	25.87	27.92	19.82	22.95
Normalized Net Income Margin	14.03	18.94	20.89	14.98	19.59
Levered Free Cash Flow Margin	1.06	-2.39	15.39	5.41	16.93
Unlevered Free Cash Flow Margin	1.97	-1.74	16.31	7.1	18.24
Asset Turnover
Asset Turnover	0.34	0.35	0.33	0.34	0.38
Fixed Assets Turnover	2.11	1.87	1.65	1.63	1.75
Receivables Turnover (Average Receivables)	5.58	5.4	5.1	6.49	7.59
Inventory Turnover (Average Inventory)	1.85	1.69	1.69	1.58	1.63
Short Term Liquidity
Current Ratio	4.6	5.49	5.44	2.47	1.71
Quick Ratio	3.67	4.33	4.63	1.85	1.36
Operating Cash Flow to Current Liabilities	0.93	1.11	1.22	0.56	0.59
Days Sales Outstanding (Average Receivables)	65.54	67.54	71.54	56.2	48.23
Days Outstanding Inventory (Average Inventory)	197.65	216.11	215.57	231.61	224.92
Average Days Payable Outstanding	55.99	67.23	72.43	67.98	55.25
Cash Conversion Cycle (Average Days)	207.2	216.42	214.67	219.82	217.9
Long Term Solvency
Total Debt/Equity	22.26	17.94	29.02	29.3	19.71
Total Debt / Total Capital	18.2	15.21	22.49	22.66	16.46
LT Debt/Equity	19.45	16.84	26.58	16.45	0.38
Long-Term Debt / Total Capital	15.91	14.28	20.6	12.72	0.32
Total Liabilities / Total Assets	25.94	23.71	29.96	30.1	25.51
EBIT / Interest Expense	16.55	25.35	18.89	9.03	13.68
EBITDA / Interest Expense	21	30.29	22.67	10.61	15.75
(EBITDA - Capex) / Interest Expense	9.98	14.82	13.67	7.67	12.18
Total Debt / EBITDA	1.71	1.3	1.95	2.15	1.18
Net Debt / EBITDA	-0.85	-1.06	-1.11	-0.51	-0.92
Total Debt / (EBITDA - Capex)	3.6	2.67	3.24	2.97	1.53
Net Debt / (EBITDA - Capex)	-1.79	-2.17	-1.84	-0.71	-1.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.07	14.22	7.48	13.84	16.53
Gross Profit, 1 Yr. Growth %	3	16.6	7.51	17.1	17.87
EBITDA, 1 Yr. Growth %	16.14	18.38	13.93	-2.18	11.95
EBITA, 1 Yr. Growth %	18.51	20.82	15.32	-3.54	11
EBIT, 1 Yr. Growth %	18.82	25.73	13.18	0.02	11.23
Earnings From Cont. Operations, 1 Yr. Growth %	-21.33	111.07	17.23	-16.9	39.79
Net Income, 1 Yr. Growth %	-14.16	97.57	15.97	-19.13	34.93
Normalized Net Income, 1 Yr. Growth %	3.15	54.19	20.04	-18.51	27.95
Diluted EPS Before Extra, 1 Yr. Growth %	-14.21	89.55	20.28	-16.01	36.11
Accounts Receivable, 1 Yr. Growth %	-3.47	40.27	-4.98	-16.52	19.18
Inventory, 1 Yr. Growth %	17.23	11.46	3.13	9.09	2.27
Net Property, Plant and Equip., 1 Yr. Growth %	28.16	28.49	16.67	12.56	5.92
Total Assets, 1 Yr. Growth %	19.37	8.68	14.45	7.34	2.49
Tangible Book Value, 1 Yr. Growth %	47.01	34.12	10.86	14.88	14.73
Common Equity, 1 Yr. Growth %	11.06	14.39	6.01	8.57	9.99
Cash From Operations, 1 Yr. Growth %	-28.76	17.39	38.14	-2.41	53.7
Capital Expenditures, 1 Yr. Growth %	89.43	15.24	-11.62	-31.4	9.11
Levered Free Cash Flow, 1 Yr. Growth %	-95.85	-356.66	-792.56	-59.97	122.91
Unlevered Free Cash Flow, 1 Yr. Growth %	-92.66	-200.74	-1.11K	-50.41	101.5
Dividend Per Share, 1 Yr. Growth %	-	-	-45.71	156.54	3.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.41	9.55	10.8	10.67	15.18
Gross Profit, 2 Yr. CAGR %	10.49	9.59	11.96	12.2	17.49
EBITDA, 2 Yr. CAGR %	4.7	17.25	16.13	5.85	14.29
EBITA, 2 Yr. CAGR %	4.55	19.66	18.04	5.68	13.97
EBIT, 2 Yr. CAGR %	4.75	22.23	19.29	6.63	16.72
Earnings From Cont. Operations, 2 Yr. CAGR %	-22.3	28.86	57.3	-1.28	7.78
Net Income, 2 Yr. CAGR %	-19.1	30.22	51.36	-3.14	4.46
Normalized Net Income, 2 Yr. CAGR %	-1.93	26.12	35.2	-0.98	11.46
Diluted EPS Before Extra, 2 Yr. CAGR %	-18.45	27.52	51	0.53	6.92
Accounts Receivable, 2 Yr. CAGR %	-18.61	16.36	15.45	-10.88	-0.25
Inventory, 2 Yr. CAGR %	26.92	14.31	7.22	6.11	5.63
Net Property, Plant and Equip., 2 Yr. CAGR %	28.94	28.33	22.44	15.06	9.19
Total Assets, 2 Yr. CAGR %	13.02	13.9	11.53	10.89	4.89
Tangible Book Value, 2 Yr. CAGR %	47.92	40.42	21.94	12.57	14.8
Common Equity, 2 Yr. CAGR %	11.39	12.71	10.12	7.13	9.28
Cash From Operations, 2 Yr. CAGR %	8.12	-8.55	27.34	14.88	22.47
Capital Expenditures, 2 Yr. CAGR %	90.02	47.75	0.92	-22.09	-13.48
Levered Free Cash Flow, 2 Yr. CAGR %	-42.27	-67.37	321.61	66.49	20.85
Unlevered Free Cash Flow, 2 Yr. CAGR %	-35.52	-72.81	218.85	123.79	21.79
Dividend Per Share, 2 Yr. CAGR %	-	-	-	18.01	62.97
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.38	11.66	8.85	11.84	12.59
Gross Profit, 3 Yr. CAGR %	13.95	12.49	8.89	13.65	14.06
EBITDA, 3 Yr. CAGR %	7.84	9.07	16.13	9.87	14.37
EBITA, 3 Yr. CAGR %	7.26	9.71	18.2	10.51	14.57
EBIT, 3 Yr. CAGR %	6.88	11.32	19.14	12.65	15.7
Earnings From Cont. Operations, 3 Yr. CAGR %	-5.87	8.41	24.86	27.18	10.86
Net Income, 3 Yr. CAGR %	-3.68	8.94	25.29	22.84	8.18
Normalized Net Income, 3 Yr. CAGR %	6.77	14.04	23.54	14.3	14.34
Diluted EPS Before Extra, 3 Yr. CAGR %	-3.64	8.03	25.06	24.2	11.22
Accounts Receivable, 3 Yr. CAGR %	-9.45	-2.42	8.76	3.67	-1.81
Inventory, 3 Yr. CAGR %	18.05	21.54	10.46	7.87	4.82
Net Property, Plant and Equip., 3 Yr. CAGR %	19.19	28.79	24.32	19.37	11.92
Total Assets, 3 Yr. CAGR %	8.73	11.55	14.08	10.15	8.02
Tangible Book Value, 3 Yr. CAGR %	58.67	43.17	29.78	19.34	13.28
Common Equity, 3 Yr. CAGR %	13.06	12.38	10.43	9.5	8.08
Cash From Operations, 3 Yr. CAGR %	7.77	11.12	4.93	15.71	26.58
Capital Expenditures, 3 Yr. CAGR %	86.14	60.84	24.49	-11.23	-12.83
Levered Free Cash Flow, 3 Yr. CAGR %	-31.51	-5.08	-9.66	92.33	116.25
Unlevered Free Cash Flow, 3 Yr. CAGR %	-26.15	-25.18	-9.31	71.51	146.51
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	12.97
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	27.27	17.94	12.93	11.26	11.36
Gross Profit, 5 Yr. CAGR %	25.89	17.11	13.15	12.37	12.25
EBITDA, 5 Yr. CAGR %	19.85	15.23	11.08	7.77	15.51
EBITA, 5 Yr. CAGR %	18.88	15.54	11.45	8.08	16.58
EBIT, 5 Yr. CAGR %	17.33	15.51	11.68	9.42	18.27
Earnings From Cont. Operations, 5 Yr. CAGR %	7.94	17.91	15.6	4.43	17.74
Net Income, 5 Yr. CAGR %	9.69	18.3	15.41	3.94	16.51
Normalized Net Income, 5 Yr. CAGR %	15.24	20.68	17.34	7.51	18.61
Diluted EPS Before Extra, 5 Yr. CAGR %	7.22	17.15	15.33	4.96	17.47
Accounts Receivable, 5 Yr. CAGR %	12.33	11.91	-0.21	-5.89	5.09
Inventory, 5 Yr. CAGR %	35.75	21.35	13.59	15.12	8.52
Net Property, Plant and Equip., 5 Yr. CAGR %	45.93	16.78	20.48	23.11	18.22
Total Assets, 5 Yr. CAGR %	21.67	11.72	9.84	11.29	10.33
Tangible Book Value, 5 Yr. CAGR %	1.31	127.25	42.81	30.04	23.44
Common Equity, 5 Yr. CAGR %	13.7	13.39	11.87	10.25	9.91
Cash From Operations, 5 Yr. CAGR %	24.18	9.46	15.21	12.61	11.15
Capital Expenditures, 5 Yr. CAGR %	71.02	54.62	45.71	20.36	7.65
Levered Free Cash Flow, 5 Yr. CAGR %	8.6	16.49	41.69	18.84	1.49
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.5	39.15	32.57	15.97	2.06
Dividend Per Share, 5 Yr. CAGR %	-	-	9.17	-	-